Dr. Perry developed the Neurosequential Model (NM) including the clinically-focused version, the Neurosequential Model of Therapeutics (NMT).  This developmentally-sensitive and neuroscience-informed approach has been used by hundreds of clinical organizations and thousands of clinicians in over thirty countries.  This evidence-based approach to clinical problem solving is also an evidence generating approach that continues to provide data about the impact of experience - good and bad - on the developing child.